메뉴 건너뛰기




Volumn 120, Issue 3, 2014, Pages 390-398

An international phase 3 trial in head and neck cancer: Quality of life and symptom results: EORTC 24954 on behalf of the EORTC head and neck and the EORTC radiation oncology group

Author keywords

alternating chemoradiotherapy; chemotherapy; European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30 (EORTC QLQ C30); health related quality of life; hypopharynx cancer; larynx cancer; radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; CONTROLLED STUDY; DYSPHAGIA; DYSPNEA; FATIGUE; HUMAN; HYPOPHARYNX CANCER; LARYNX SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; SENSITIVITY ANALYSIS; SPEECH DISORDER; SYMPTOM; TUMOR CLASSIFICATION;

EID: 84892941909     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28392     Document Type: Article
Times cited : (34)

References (19)
  • 1
    • 0003964361 scopus 로고    scopus 로고
    • American Cancer Society. Atlanta, GA: American Cancer Society
    • American Cancer Society. Cancer Facts and Figures 2010. Atlanta, GA: American Cancer Society; 2010.
    • (2010) Cancer Facts and Figures 2010
  • 3
    • 0028362304 scopus 로고
    • Speech and swallowing function after oral and oropharyngeal resections: 1-year follow-up
    • Pauloski BR, Logemann JA, Rademaker AW, et al. Speech and swallowing function after oral and oropharyngeal resections: 1-year follow-up. Head Neck. 1994; 16: 313-322.
    • (1994) Head Neck , vol.16 , pp. 313-322
    • Pauloski, B.R.1    Logemann, J.A.2    Rademaker, A.W.3
  • 4
    • 59749096455 scopus 로고    scopus 로고
    • EORTC Head and Neck Cancer Cooperative Group; EORTC Radiation Oncology Group. Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy
    • Lefebvre JL, Rolland F, Tesselaar M, et al. EORTC Head and Neck Cancer Cooperative Group; EORTC Radiation Oncology Group. Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy. J Natl Cancer Inst. 2009; 101: 142-152.
    • (2009) J Natl Cancer Inst. , vol.101 , pp. 142-152
    • Lefebvre, J.L.1    Rolland, F.2    Tesselaar, M.3
  • 5
    • 0027417437 scopus 로고
    • The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology
    • Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993; 85: 365-376.
    • (1993) J Natl Cancer Inst. , vol.85 , pp. 365-376
    • Aaronson, N.K.1    Ahmedzai, S.2    Bergman, B.3
  • 6
    • 0032980277 scopus 로고    scopus 로고
    • Quality of life in head and neck cancer patients: Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35
    • Bjordal K, Hammerlid E, Ahlner-Elmqvist M, et al. Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. J Clin Oncol. 1999; 17: 1008 -1019.
    • (1999) J Clin Oncol. , vol.17 , pp. 1008-1019
    • Bjordal, K.1    Hammerlid, E.2    Ahlner-Elmqvist, M.3
  • 7
    • 0036711431 scopus 로고    scopus 로고
    • Health related quality of life assessment methodology and reported outcomes in randomised controlled trials of primary brain cancer patients
    • Efficace F, Bottomley A,. Health related quality of life assessment methodology and reported outcomes in randomised controlled trials of primary brain cancer patients. Eur J Cancer. 2002; 38: 1824-1831.
    • (2002) Eur J Cancer. , vol.38 , pp. 1824-1831
    • Efficace, F.1    Bottomley, A.2
  • 8
    • 0033869723 scopus 로고    scopus 로고
    • A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group
    • Bjordal K, de Graeff A, Fayers PM, et al. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. Eur J Cancer. 2000; 36: 1796-1807.
    • (2000) Eur J Cancer. , vol.36 , pp. 1796-1807
    • Bjordal, K.1    De Graeff, A.2    Fayers, P.M.3
  • 12
    • 23744459243 scopus 로고    scopus 로고
    • European Organisation for Research and Treatment of Cancer (EORTC) Data Center and Quality of Life Group. Health related quality of life outcomes in cancer clinical trials
    • Bottomley A, Flechtner H, Efficace F, et al. European Organisation for Research and Treatment of Cancer (EORTC) Data Center and Quality of Life Group. Health related quality of life outcomes in cancer clinical trials. Eur J Cancer. 2005; 41: 1697-1709.
    • (2005) Eur J Cancer. , vol.41 , pp. 1697-1709
    • Bottomley, A.1    Flechtner, H.2    Efficace, F.3
  • 13
    • 0031972496 scopus 로고    scopus 로고
    • Interpreting the significance of changes in health-related quality-of-life scores
    • Osoba D, Rodrigues G, Myles J, et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998; 16: 139-144.
    • (1998) J Clin Oncol. , vol.16 , pp. 139-144
    • Osoba, D.1    Rodrigues, G.2    Myles, J.3
  • 15
    • 77958002438 scopus 로고    scopus 로고
    • EORTC Head and Neck Group. Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971/TAX 323)
    • van Herpen CML, Mauer ME, Mesia R, et al; EORTC Head and Neck Group. Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971/TAX 323). Br J Cancer. 2010; 103: 1173-1181.
    • (2010) Br J Cancer. , vol.103 , pp. 1173-1181
    • Van Herpen, C.M.L.1    Mauer, M.E.2    Mesia, R.3
  • 17
    • 34250218226 scopus 로고    scopus 로고
    • Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab
    • Curran D, Giralt J, Harari PM, et al. Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab. J Clin Oncol. 2007; 25: 2191-2197.
    • (2007) J Clin Oncol. , vol.25 , pp. 2191-2197
    • Curran, D.1    Giralt, J.2    Harari, P.M.3
  • 18
    • 34047134943 scopus 로고    scopus 로고
    • A systematic review of patient-reported outcome measures in head and neck cancer surgery
    • Pusic A, Liu JC, Chen CM, et al. A systematic review of patient-reported outcome measures in head and neck cancer surgery. Otolaryngol Head Neck Surg. 2007; 136: 525-535.
    • (2007) Otolaryngol Head Neck Surg. , vol.136 , pp. 525-535
    • Pusic, A.1    Liu, J.C.2    Chen, C.M.3
  • 19
    • 0036227350 scopus 로고    scopus 로고
    • The cancer patient and quality of life
    • Bottomley A,. The cancer patient and quality of life. Oncologist. 2002; 7: 120-125.
    • (2002) Oncologist , vol.7 , pp. 120-125
    • Bottomley, A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.